Muramatsu SI - Search Results

1

Neurotransmitter release: vacuolar ATPase V0 sector c-subunits in possible gene or cell therapies for Parkinson's, Alzheimer's, and psychiatric diseases.

Higashida H, Yokoyama S, Tsuji C, Muramatsu SI. Higashida H, et al. Among authors: muramatsu si. J Physiol Sci. 2017 Jan;67(1):11-17. doi: 10.1007/s12576-016-0462-3. Epub 2016 Jun 11. J Physiol Sci. 2017. PMID: 27289535 Free PMC article. Review.

2

[Gene therapy for Parkinson's disease].

Muramatsu S. Muramatsu S. Nihon Rinsho. 2004 Sep;62(9):1648-52. Nihon Rinsho. 2004. PMID: 15462379 Review. Japanese.

3

[Gene therapy and cell transplantation for Parkinson's disease].

Muramatsu S. Muramatsu S. Rinsho Shinkeigaku. 2005 Nov;45(11):902-4. Rinsho Shinkeigaku. 2005. PMID: 16447758 Review. Japanese.

4

[Gene therapy for Parkinson's disease].

Muramatsu S. Muramatsu S. Brain Nerve. 2007 Apr;59(4):425-30. Brain Nerve. 2007. PMID: 17447529 Review. Japanese.

5

[Cell therapy for Parkinson disease].

Muramatsu S. Muramatsu S. Rinsho Shinkeigaku. 2009 Nov;49(11):890-2. doi: 10.5692/clinicalneurol.49.890. Rinsho Shinkeigaku. 2009. PMID: 20030240 Review. Japanese.

6

A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease.

Muramatsu S, Fujimoto K, Kato S, Mizukami H, Asari S, Ikeguchi K, Kawakami T, Urabe M, Kume A, Sato T, Watanabe E, Ozawa K, Nakano I. Muramatsu S, et al. Mol Ther. 2010 Sep;18(9):1731-5. doi: 10.1038/mt.2010.135. Epub 2010 Jul 6. Mol Ther. 2010. PMID: 20606642 Free PMC article. Clinical Trial.

7

[Gene therapy for Parkinson disease].

Muramatsu S. Muramatsu S. Nihon Rinsho. 2010 Aug;68 Suppl 8:646-9. Nihon Rinsho. 2010. PMID: 20976940 Review. Japanese. No abstract available.

8

Dopamine release via the vacuolar ATPase V0 sector c-subunit, confirmed in N18 neuroblastoma cells, results in behavioral recovery in hemiparkinsonian mice.

Jin D, Muramatsu S, Shimizu N, Yokoyama S, Hirai H, Yamada K, Liu HX, Higashida C, Hashii M, Higashida A, Asano M, Ohkuma S, Higashida H. Jin D, et al. Neurochem Int. 2012 Nov;61(6):907-12. doi: 10.1016/j.neuint.2011.12.021. Epub 2012 Jan 14. Neurochem Int. 2012. PMID: 22265874

9

[Gene therapy for Parkinson's disease].

Muramatsu S. Muramatsu S. Rinsho Shinkeigaku. 2012;52(11):896-8. doi: 10.5692/clinicalneurol.52.896. Rinsho Shinkeigaku. 2012. PMID: 23196456 Japanese.

10

Gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors.

Ozawa K, Fan DS, Shen Y, Muramatsu S, Fujimoto K, Ikeguchi K, Ogawa M, Urabe M, Kume A, Nakano I. Ozawa K, et al. J Neural Transm Suppl. 2000;(58):181-91. doi: 10.1007/978-3-7091-6284-2_15. J Neural Transm Suppl. 2000. PMID: 11128607 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

310 results

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

310 results